Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aigner

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Anticancer Research|January 1, 1982
Tissue toxicity of cis-platinum in hyperthermic isolated extremity perfusionP Hild, K Aigner, K Schwemmle, et al.
Anticancer Research|March 1, 1983
Isolated extremity perfusion with DTIC. An experimental and clinical studyK Aigner, P Hild, H Breithaupt, et al.
American Journal of Clinical Oncology|October 1, 1991
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II StudyD Khayat, V Cour, J P Bizzari, et al.
Cancer Research|January 1, 1992
Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reactionT Horikoshi, K D Danenberg, T H Stadlbauer, et al.
Wiener Klinische Wochenschrift|October 23, 1997
Phase II trial of gemcitabine in advanced non-small-cell lung cancerR Malayeri, E Ulsperger, G Baumgartner, et al.
Oncogene|May 9, 2007
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarityK Aigner, B Dampier, L Descovich, et al.
Wiener Medizinische Wochenschrift (1946)|July 25, 1998
[The "Inpatient Vaccination" Project in upper Austria. Technical report]G Süss, K Aigner, J Bolitschek, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Anticancer Research|January 1, 1982
Tissue toxicity of cis-platinum in hyperthermic isolated extremity perfusionP Hild, K Aigner, K Schwemmle, et al.
Anticancer Research|March 1, 1983
Isolated extremity perfusion with DTIC. An experimental and clinical studyK Aigner, P Hild, H Breithaupt, et al.
American Journal of Clinical Oncology|October 1, 1991
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II StudyD Khayat, V Cour, J P Bizzari, et al.
Cancer Research|January 1, 1992
Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reactionT Horikoshi, K D Danenberg, T H Stadlbauer, et al.
Wiener Klinische Wochenschrift|October 23, 1997
Phase II trial of gemcitabine in advanced non-small-cell lung cancerR Malayeri, E Ulsperger, G Baumgartner, et al.
Oncogene|May 9, 2007
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarityK Aigner, B Dampier, L Descovich, et al.
Wiener Medizinische Wochenschrift (1946)|July 25, 1998
[The "Inpatient Vaccination" Project in upper Austria. Technical report]G Süss, K Aigner, J Bolitschek, et al.
Pageof 8